Management — NMD Pharma
Company Presentation
NMD Pharma - PIR International
NMD bags €38M to run orphan neuromuscular disease trials | FierceBiotech
Denmark in New York on Twitter: "#DKBIO17 is "a great opportunity for us to broaden our scope and look for investors.” - Thomas H. Pedersen, CEO, NMD Pharma… https://t.co/AUeO5JqgX6"
NMD Pharma
NMD Pharma company information, funding & investors | Dealroom.co
Big deal: NMD flexes series A muscles - Global University Venturing
NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma, finalist i Life Sciences kategorien - EY Danmark
NMD Pharma — NMD Pharma
NMD Pharma brænder 41 mio. kr. af sin kæmpeinvestering
NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma, finalist i Life Sciences kategorien - EY Danmark
NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
NMD Pharma
Tunge pengetanke klar til nye investeringer i biotekselskab fra Aarhus
Prominent Canadian researcher in Denmark: Why I left a top job in California
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
Management — NMD Pharma
Investors — NMD Pharma
NMD Pharma
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
NMD Pharma Receives Approval to Start a combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
NMD Pharma company information, funding & investors | Dealroom.co
Roel Bulthuis - Director at NMD Pharma | The Org
Contact — NMD Pharma
